Lyell Immunopharma, Inc. (LYEL)
NASDAQ·Healthcare·Biotechnology
$13.45
-2.00%
Mkt Cap $279.31M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$46.00
Range $44.00 – $49.00
Implied Upside
+242.1%
Consensus $46.00 vs current $13.45
NASDAQ·Healthcare·Biotechnology
$13.45
-2.00%
Mkt Cap $279.31M
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$46.00
Range $44.00 – $49.00
+242.1%
Consensus $46.00 vs current $13.45